pillbase.ru

Hemgenix

Active substance: etranacogene dezaparvovec

Etranacogene dezaparvovec

Centralised EU authorisationActive

Marketing holder: CSL Behring GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 39
  • HEMGENIX
    KIT · etranacogene dezaparvovec
    0053-0110
    CSL Behring
  • HEMGENIX
    KIT · etranacogene dezaparvovec
    0053-0140
    CSL Behring
  • HEMGENIX
    KIT · etranacogene dezaparvovec
    0053-0160
    CSL Behring
  • HEMGENIX
    KIT · etranacogene dezaparvovec
    0053-0310
    CSL Behring
  • HEMGENIX
    KIT · etranacogene dezaparvovec
    0053-0260
    CSL Behring
All products in this country (39)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-982a-791c-9567-512a52bdf35e,01a1208c-9886-73ea-a4e0-cd73e7b92337,01a1208c-98c1-7205-80d5-2027e6c0ba11,01a1208c-9bd6-75f4-b2c8-2e8fe6259c2c,01a1208d-7b6c-7c49-887e-0095104b2ad9;count=39 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004827
Registration status
Active
ATC code
B02BD
Sources
  • product · EMA · EMEA/H/C/004827 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004827 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004827 · Verified 2026-10-09